retatrutide triple agonist weight loss trial 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist drug that is STILL IN CLINICAL TRIALS, is showing incredible results, with some Eli Lilly's triple agonist, retatrutide,

Our experienced providers work with you to develop a plan tailored to your health history, lifestyle, and goals, ensuring that you receive the most effective care for lasting results

In Phase 2 trials, 91.7% of Retatrutide users achieved at least 10% weight loss

You may receive placebo, but even that comes with regular medical monitoring that many people do not otherwise get

The New England Journal of Medicine, 388(11), 961963

As such, Ive listed some of the options each program provides for accommodating specific diets

ShedRxs lose 10% of your weight or full refund promise is a contractual refund policy full money back if you do not lose at least 10% of your body weight on the program